These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
4. Post-treatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion. Ravikumar R; McEwen ML; Springer JE J Neurotrauma; 2007 Oct; 24(10):1618-30. PubMed ID: 17970625 [TBL] [Abstract][Full Text] [Related]
5. Acute, subacute and chronic effect of cyclosporin-A on mean arterial pressure of rats with severe spinal cord contusion. Romero SE; Bravo G; Hong E; Rojas G; Ibarra A Neurosci Lett; 2008 Nov; 445(1):99-102. PubMed ID: 18775474 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. Rabchevsky AG; Fugaccia I; Sullivan PG; Scheff SW J Neurotrauma; 2001 May; 18(5):513-22. PubMed ID: 11393254 [TBL] [Abstract][Full Text] [Related]
7. Potential adverse effects of cyclosporin A on kidneys after spinal cord injury. Lonjon N; Boniface G; Feifel R; Endres R; Gimenez y Ribotta M; Privat A; Perrin FE Spinal Cord; 2011 Mar; 49(3):472-9. PubMed ID: 20838405 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats. McEwen ML; Sullivan PG; Springer JE J Neurotrauma; 2007 Apr; 24(4):613-24. PubMed ID: 17439345 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of cyclosporin-A in spinal cord injury: an overview. Ibarra A; Diaz-Ruiz A Curr Med Chem; 2006; 13(22):2703-10. PubMed ID: 17017921 [TBL] [Abstract][Full Text] [Related]
16. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845 [TBL] [Abstract][Full Text] [Related]
17. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945 [TBL] [Abstract][Full Text] [Related]
18. The effects of cyclosporin-A on functional outcome and axonal regrowth following spinal cord injury in adult rats. Roozbehi A; Joghataie MT; Mehdizadeh M; Mirzaei A; Delaviz H Acta Med Iran; 2012; 50(4):226-32. PubMed ID: 22592571 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. Steffan J; Strehlau G; Maurer M; Rohlfs A J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852 [TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Ibarra A; Correa D; Willms K; Merchant MT; Guizar-Sahagún G; Grijalva I; Madrazo I Brain Res; 2003 Jul; 979(1-2):165-78. PubMed ID: 12850583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]